{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-23-027767","form_type":"8-K","ticker":"ZLAB","cik":"0001704292","company_name":"Zai Lab Ltd","filed_at":"2023-08-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:34.918828+00:00","generated_at":"2026-06-12T04:30:27.368886+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Zai Lab Q2 product rev $68.9M (+45% YoY); VYVGART approved in China; net loss $120.9M","bullets":["Product revenue $68.9M, up 45% YoY (53% constant currency); driven by ZEJULA $43.0M, Optune $13.7M.","Net loss $120.9M ($0.13 loss per ADS) vs $137.9M loss a year ago; R&D spend $76.7M, SG&A $67.9M.","Cash $876.4M as of June 30, 2023; down from $931.4M at March 31, 2023.","NMPA approved VYVGART (efgartigimod) for gMG; launch preparation underway; NRDL listing eligible for 2024.","Promoted Yajing Chen to CFO effective July 7, 2023; targeting corporate profitability by end of 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-23-027767","json":"https://secwatch.observer/filing/0001628280-23-027767.json","markdown":"https://secwatch.observer/filing/0001628280-23-027767.md","text":"https://secwatch.observer/filing/0001628280-23-027767.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1704292/000162828023027767/0001628280-23-027767-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1704292/000162828023027767/zlab-20230807.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T04:30:27.368886+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"52dd4c1f8908d189c495a5fadeeb05ebf6492f58","claim":"Zai Lab Ltd reported the second quarter of 2023 results: revenue $68.9 million.","evidence_excerpt":"Total product revenue of $68.9 million for the second quarter of 2023","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1704292/000162828023027767/0001628280-23-027767-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the second quarter of 2023"},{"label":"Revenue","value":"$68.9 million"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}